Tech Company Financing Transactions
BioSET Funding Round
On 6/8/2007, BioSET raised $11 million in funding from PTV Sciences, EDF Ventures and Heron Capital.
Transaction Overview
Company Name
Announced On
6/8/2007
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Undisclosed
Investors
Proceeds Purpose
BioSET CEO and President Tom Roueche said, "This financing will allow us to commence human clinical trials with our lead synthetic B2A growth factor product for spine fusion, and also will permit the company to accelerate the pre-clinical development of additional growth factor mimetics the company has identified."
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9430 Key West Ave. 220
Rockville, MD 20850
USA
Rockville, MD 20850
USA
Phone
Website
Email Address
Overview
BioSET is leading an orthobiologic revolution, a step beyond growth factors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
William Mavity
Chief Executive Officer
Thomas Rouech
Chief Scientific Officer
Paul Zamora
VP - Regulatory Affairs
Bruce Burlington
Browse more venture capital transactions:
Prev: 6/8/2007: Blue Noodle venture capital transaction
Next: 6/11/2007: Eye-Fi venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs